Achiko AG Logo

Achiko AG

ACHI | SW

Overview

Corporate Details

ISIN(s):
CH0522213468
LEI:
Country:
Switzerland
Address:
Tessinerplatz 7, 8002 Zürich
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Achiko AG was a health technology company that developed aptamer-based diagnostic solutions and companion mobile health applications. Its primary products included AptameX™, a biotechnology division for diagnostics, and Teman Sehat, a digital health passport app. The company focused on creating an ecosystem for COVID-19 management by integrating a rapid, low-cost test with its mobile software. As of July 2023, the company is in liquidation and has been delisted from the Swiss Stock Exchange.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Achiko AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-12-21 06:45
Regulatory News Service
Achiko AG Production and Sales Update
English 13.2 KB
2022-12-21 01:00
Earnings Release
Achiko AG Production and Sales Update
English 11.1 KB
2022-12-21 01:00
Earnings Release
Achiko AG Produktions- und Vertriebsupdate
German 18.3 KB
2022-12-20 18:00
Post-Annual General Meeting Information
2022 Ordinary Shareholders Meeting of Achiko AG: Shareholders adopt all proposa…
English 9.6 KB
2022-12-20 01:00
Post-Annual General Meeting Information
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all propos…
English 8.0 KB
2022-12-20 01:00
Post-Annual General Meeting Information
Ordentliche Generalversammlung 2022 der Achiko AG: Aktionäre nehmen alle Anträg…
German 8.5 KB
2022-11-25 18:10
Pre-Annual General Meeting Information
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 15.9 KB
2022-11-25 01:00
Pre-Annual General Meeting Information
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 14.4 KB
2022-11-25 01:00
Pre-Annual General Meeting Information
Die Achiko AG lädt ihre Aktionäre zur ordentlichen Hauptversammlung am 20. Deze…
German 14.4 KB
2022-11-17 16:10
Investor Presentation
Achiko AG Announces Corporate Update Webcast
English 16.9 KB
2022-11-17 01:00
Regulatory News Service
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-17 01:00
Regulatory News Service
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 15.0 KB
2022-11-16 16:20
Report Publication Announcement
Achiko AG Announces Corporate Update Webcast
English 17.0 KB
2022-11-16 01:00
Regulatory News Service
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-16 01:00
Report Publication Announcement
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 14.9 KB

Automate Your Workflow. Get a real-time feed of all Achiko AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Achiko AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Purple Biotech Ltd. Logo
Develops first-in-class cancer therapies targeting tumor immune evasion and drug resistance.
Israel PPBT
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom QBT
Quantum Genomics Logo
Develops digital twin solutions to simulate drug effects and personalize treatments.
France ALQGC
QUIA PHARMA AB Logo
Develops enhanced drugs using a patented, releasable pegylation drug delivery platform.
Sweden QUIA
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland RLF
Respiratorius AB Logo
Developing innovative drug candidates to enhance standard therapies for aggressive cancers.
Sweden RESP
ROQUEFORT THERAPEUTICS PLC Logo
Developing novel immuno-oncology medicines for hard-to-treat, resistant cancers.
United Kingdom ROQ
United States of America N/A